Automated determination of drugs in serum by liquid chromatography with column-switching. I Separation of antiepileptic drugs and metabolites

K. Matsumoto, Haruhito Kikuchi, S. Kano, H. Iri, H. Takahashi, M. Umino

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

This is a fully automated system for determining six common antiepileptic drugs and two principal metabolites of carbamazepine in serum. It is base on 'high-performance' liquid chromatography (HPLC), with column switching. TSKprecolumn BSA-ODS and TSKgel ODS-120A (both from Toyo Soda) were used as the precolumn and analytical column, repectively. The former contains octadecylsilyl resins treated with bovine serum albumin (BSA), and does not adsorb macromolecules such as serum proteins but retains small lipophilic molecules such as antiepileptic drugs. Serum samples are directly injected onto the precolumn. After washing out the serum proteins from the precolumn with sodium phosphate buffer, we switch the column connections to introduce the retained substances onto the analytical column and elute with a step-gradient of acetonitrile/sodium phosphate buffer. The high analytical recovery (95-102%) and the reproducibilities (CV <5% within-run) indicate that this system is suitable for use in therapeutic drug monitoring in clinical laboratories.

Original languageEnglish
Pages (from-to)141-144
Number of pages4
JournalClinical Chemistry
Volume34
Issue number1
Publication statusPublished - 1988

Fingerprint

Liquid chromatography
Bovine Serum Albumin
Metabolites
Liquid Chromatography
Anticonvulsants
Blood Proteins
Buffers
Clinical laboratories
Drug Monitoring
Carbamazepine
High performance liquid chromatography
Serum
Macromolecules
Washing
Pharmaceutical Preparations
Resins
High Pressure Liquid Chromatography
Switches
Recovery
Molecules

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Automated determination of drugs in serum by liquid chromatography with column-switching. I Separation of antiepileptic drugs and metabolites. / Matsumoto, K.; Kikuchi, Haruhito; Kano, S.; Iri, H.; Takahashi, H.; Umino, M.

In: Clinical Chemistry, Vol. 34, No. 1, 1988, p. 141-144.

Research output: Contribution to journalArticle

@article{7e8a563dbca442dcbae3104978098b1f,
title = "Automated determination of drugs in serum by liquid chromatography with column-switching. I Separation of antiepileptic drugs and metabolites",
abstract = "This is a fully automated system for determining six common antiepileptic drugs and two principal metabolites of carbamazepine in serum. It is base on 'high-performance' liquid chromatography (HPLC), with column switching. TSKprecolumn BSA-ODS and TSKgel ODS-120A (both from Toyo Soda) were used as the precolumn and analytical column, repectively. The former contains octadecylsilyl resins treated with bovine serum albumin (BSA), and does not adsorb macromolecules such as serum proteins but retains small lipophilic molecules such as antiepileptic drugs. Serum samples are directly injected onto the precolumn. After washing out the serum proteins from the precolumn with sodium phosphate buffer, we switch the column connections to introduce the retained substances onto the analytical column and elute with a step-gradient of acetonitrile/sodium phosphate buffer. The high analytical recovery (95-102{\%}) and the reproducibilities (CV <5{\%} within-run) indicate that this system is suitable for use in therapeutic drug monitoring in clinical laboratories.",
author = "K. Matsumoto and Haruhito Kikuchi and S. Kano and H. Iri and H. Takahashi and M. Umino",
year = "1988",
language = "English",
volume = "34",
pages = "141--144",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "1",

}

TY - JOUR

T1 - Automated determination of drugs in serum by liquid chromatography with column-switching. I Separation of antiepileptic drugs and metabolites

AU - Matsumoto, K.

AU - Kikuchi, Haruhito

AU - Kano, S.

AU - Iri, H.

AU - Takahashi, H.

AU - Umino, M.

PY - 1988

Y1 - 1988

N2 - This is a fully automated system for determining six common antiepileptic drugs and two principal metabolites of carbamazepine in serum. It is base on 'high-performance' liquid chromatography (HPLC), with column switching. TSKprecolumn BSA-ODS and TSKgel ODS-120A (both from Toyo Soda) were used as the precolumn and analytical column, repectively. The former contains octadecylsilyl resins treated with bovine serum albumin (BSA), and does not adsorb macromolecules such as serum proteins but retains small lipophilic molecules such as antiepileptic drugs. Serum samples are directly injected onto the precolumn. After washing out the serum proteins from the precolumn with sodium phosphate buffer, we switch the column connections to introduce the retained substances onto the analytical column and elute with a step-gradient of acetonitrile/sodium phosphate buffer. The high analytical recovery (95-102%) and the reproducibilities (CV <5% within-run) indicate that this system is suitable for use in therapeutic drug monitoring in clinical laboratories.

AB - This is a fully automated system for determining six common antiepileptic drugs and two principal metabolites of carbamazepine in serum. It is base on 'high-performance' liquid chromatography (HPLC), with column switching. TSKprecolumn BSA-ODS and TSKgel ODS-120A (both from Toyo Soda) were used as the precolumn and analytical column, repectively. The former contains octadecylsilyl resins treated with bovine serum albumin (BSA), and does not adsorb macromolecules such as serum proteins but retains small lipophilic molecules such as antiepileptic drugs. Serum samples are directly injected onto the precolumn. After washing out the serum proteins from the precolumn with sodium phosphate buffer, we switch the column connections to introduce the retained substances onto the analytical column and elute with a step-gradient of acetonitrile/sodium phosphate buffer. The high analytical recovery (95-102%) and the reproducibilities (CV <5% within-run) indicate that this system is suitable for use in therapeutic drug monitoring in clinical laboratories.

UR - http://www.scopus.com/inward/record.url?scp=0023873276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023873276&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 141

EP - 144

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 1

ER -